ID

23807

Descripción

Fluorouracil and Leucovorin Plus Either Irinotecan or Oxaliplatin With or Without Cetuximab in Treating Patients With Previously Untreated Metastatic Adenocarcinoma of the Colon or Rectum https://clinicaltrials.gov/ct2/show/NCT00077233

Link

https://clinicaltrials.gov/ct2/show/NCT00077233

Palabras clave

  1. 27/8/12 27/8/12 -
  2. 14/7/17 14/7/17 - Martin Dugas
Subido en

14 de julio de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Metastatic Colorectal Cancer Fluorouracil Leucovorin Irinotecan Oxaliplatin NCT00077233 CALGB 80203

No Instruction available.

  1. StudyEvent: CALGB: 80203 DERMATOLOGY SPECIFIC QUALITY-OF-LIFE QUESTIONNAIRE (DSQL)
    1. No Instruction available.
Header
Descripción

Header

Alias
UMLS CUI-1
C1320722
Patient Initials
Descripción

Patient Initials

Tipo de datos

text

Alias
UMLS CUI [1]
C2986440
Patient Hospital No.
Descripción

Patient Hospital Number

Tipo de datos

text

Alias
UMLS CUI [1]
C0421459
Institution/Affiliate
Descripción

Institution/Affiliate

Tipo de datos

text

Alias
UMLS CUI [1]
C1301943
Participating Group
Descripción

Participating Group

Tipo de datos

text

Alias
UMLS CUI [1]
C2347449
Participating Group Protocol No.
Descripción

Participating Group Protocol Number

Tipo de datos

text

Alias
UMLS CUI [1,1]
C3274381
UMLS CUI [1,2]
C2347449
Participating Group Patient ID
Descripción

Participating Group Patient ID

Tipo de datos

text

Alias
UMLS CUI [1]
C2348585
CALGB Study No.
Descripción

CALGB Study Number

Tipo de datos

text

Alias
UMLS CUI [1,1]
C3274381
UMLS CUI [1,2]
C1516238
CALGB Patient ID
Descripción

CALGB Patient ID

Tipo de datos

text

Alias
UMLS CUI [1,1]
C2348585
UMLS CUI [1,2]
C1516238
Are data amended
Descripción

Data amended

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1691222
Cetuximab Skin Toxicities
Descripción

Cetuximab Skin Toxicities

Alias
UMLS CUI-1
C0995188
UMLS CUI-2
C1167791
Mark with an X if there are none
Descripción

No adverse event

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1963761
MedDRA
Descripción

MedDRA

Tipo de datos

text

Alias
UMLS CUI [1]
C1140263
Adverse event term
Descripción

Adverse event term

Tipo de datos

integer

Alias
UMLS CUI [1]
C2826934
Other, specify
Descripción

Other,specify

Tipo de datos

text

Alias
UMLS CUI [1]
C3845569
Adverse event grade
Descripción

Adverse event grade

Tipo de datos

integer

Alias
UMLS CUI [1]
C2985911
Cetuximab Dose Modification
Descripción

Cetuximab Dose Modification

Tipo de datos

integer

Alias
UMLS CUI [1,1]
C0995188
UMLS CUI [1,2]
C1707811
Adverse event onset date
Descripción

Adverse event onset date

Tipo de datos

date

Alias
UMLS CUI [1]
C2985916
Adverse event end date
Descripción

Adverse event end date

Tipo de datos

date

Alias
UMLS CUI [1]
C2697886
If ongoing mark with an X
Descripción

Adverse event ongoing

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2826663
Completed by
Descripción

Completed by

Tipo de datos

text

Alias
UMLS CUI [1]
C1550483
Date form originally completed
Descripción

Date form originally completed

Tipo de datos

date

Alias
UMLS CUI [1]
C1549507

Similar models

No Instruction available.

  1. StudyEvent: CALGB: 80203 DERMATOLOGY SPECIFIC QUALITY-OF-LIFE QUESTIONNAIRE (DSQL)
    1. No Instruction available.
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Header
C1320722 (UMLS CUI-1)
Patient Initials
Item
Patient Initials
text
C2986440 (UMLS CUI [1])
Patient Hospital Number
Item
Patient Hospital No.
text
C0421459 (UMLS CUI [1])
Institution/Affiliate
Item
Institution/Affiliate
text
C1301943 (UMLS CUI [1])
Participating Group
Item
Participating Group
text
C2347449 (UMLS CUI [1])
Participating Group Protocol Number
Item
Participating Group Protocol No.
text
C3274381 (UMLS CUI [1,1])
C2347449 (UMLS CUI [1,2])
Participating Group Patient ID
Item
Participating Group Patient ID
text
C2348585 (UMLS CUI [1])
CALGB Study Number
Item
CALGB Study No.
text
C3274381 (UMLS CUI [1,1])
C1516238 (UMLS CUI [1,2])
CALGB Patient ID
Item
CALGB Patient ID
text
C2348585 (UMLS CUI [1,1])
C1516238 (UMLS CUI [1,2])
Data amended
Item
Are data amended
boolean
C1691222 (UMLS CUI [1])
Item Group
Cetuximab Skin Toxicities
C0995188 (UMLS CUI-1)
C1167791 (UMLS CUI-2)
No adverse event
Item
Mark with an X if there are none
boolean
C1963761 (UMLS CUI [1])
MedDRA
Item
MedDRA
text
C1140263 (UMLS CUI [1])
Item
Adverse event term
integer
C2826934 (UMLS CUI [1])
Code List
Adverse event term
CL Item
Rash/desquamation (1)
C1559142 (UMLS CUI-1)
CL Item
Pruritus (2)
C0033774 (UMLS CUI-1)
CL Item
Erythema multiforme (3)
C0014742 (UMLS CUI-1)
CL Item
Nail changes (4)
C0234909 (UMLS CUI-1)
CL Item
Dry skin (5)
C0151908 (UMLS CUI-1)
CL Item
Other, specify (6)
C3845569 (UMLS CUI-1)
Other,specify
Item
Other, specify
text
C3845569 (UMLS CUI [1])
Item
Adverse event grade
integer
C2985911 (UMLS CUI [1])
Code List
Adverse event grade
CL Item
1 (1)
CL Item
2 (2)
CL Item
3 (3)
CL Item
4 (4)
CL Item
5 (5)
Item
Cetuximab Dose Modification
integer
C0995188 (UMLS CUI [1,1])
C1707811 (UMLS CUI [1,2])
Code List
Cetuximab Dose Modification
CL Item
Dose held (1)
C0178602 (UMLS CUI-1)
C0549178 (UMLS CUI-2)
CL Item
Dose reduced (2)
C1707814 (UMLS CUI-1)
CL Item
Drug discontinued (3)
C0558681 (UMLS CUI-1)
Adverse event onset date
Item
Adverse event onset date
date
C2985916 (UMLS CUI [1])
Adverse event end date
Item
Adverse event end date
date
C2697886 (UMLS CUI [1])
Adverse event ongoing
Item
If ongoing mark with an X
boolean
C2826663 (UMLS CUI [1])
Completed by
Item
Completed by
text
C1550483 (UMLS CUI [1])
Date form originally completed
Item
Date form originally completed
date
C1549507 (UMLS CUI [1])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial